Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects

OBJECTIVE: Icosapent ethyl (IPE) is a prescription form of eicosapentaenoic acid (EPA) ethyl ester. This randomized, open-label study characterized EPA pharmacokinetics. METHODS: Four healthy subject groups received IPE for 28 days: three received 2 g/day (1 × 1,000 mg BID, 2 × 1,000 mg QD, or 2 × 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Braeckman, Rene A, Stirtan, William G, Soni, Paresh N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467252/
https://www.ncbi.nlm.nih.gov/pubmed/26097787
http://dx.doi.org/10.1002/cpdd.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467252/
https://www.ncbi.nlm.nih.gov/pubmed/26097787
http://dx.doi.org/10.1002/cpdd.84

Ejemplares similares